IBD Drive Time: Jimmy Limdi, MD, on the Best of ECCO by Gastroenterology Learning Network

Bharati Kochar, MD, on Pharmacoequity for Older Patients With IBD by Gastroenterology Learning Network

IBD Drive Time: Patrick Young, MD, on Ergonomics and Endoscopy by Gastroenterology Learning Network

Corey Siegel, MD, on Treating Acute Severe Ulcerative Colitis by Gastroenterology Learning Network

Siddarth Singh: AGA Guidelines on Using Biomarkers in Ulcerative Colitis by Gastroenterology Learning Network

Dr Millie Long and her IBD Drive Time cohost, Dr Raymond Cross, talk about ways health insurers create barriers to timely treatment for inflammatory bowel disease, particularly through requirements for prior authorization.

Drs Ryan Ungaro and Priscila Santiago on Risk Factors Predicting Complicated IBD by Gastroenterology Learning Network

Dr Brian Lacy welcomes Dr Timothy Gardner to talk about acute pancreatitis.

Eric Benchimol, MD, on Pediatric IBD: The Year in Review by Gastroenterology Learning Network

The results of the ATLANTIS trial showed that patients taking amitriptyline were almost twice as likely to report an overall improvement in symptoms of irritable bowel syndrome as those taking a placebo. Co-chief investigator Alexander Ford, MD, explains the results and the implications.